There is encouraging news for the ALS community as bipartisan support continues to grow in Congress. The Senate version of the ACT for ALS Reauthorization Act has been introduced by Senators Lisa Murkowski (R-AK) and Chris Coons (D-DE), marking an important step forward in ensuring continued progress in ALS research and expanded access to promising investigational therapies for people living with ALS.
Since it was first enacted in 2021, the ACT for ALS initiative has helped accelerate research and expand access to promising therapies. It has supported critical efforts like natural history studies, biomarker research, shared data resources, and expanded access programs, helping reach people with ALS who may not be eligible for traditional clinical trials. These efforts bring hope to families by moving science forward while also opening doors to potential treatment options.
As ALS United Mid-Atlantic sees every day through its care services and advocacy work, access to research and innovative therapies can make a real difference for families navigating an ALS diagnosis. Continued investment in these efforts helps move science forward while also offering hope and connection to emerging opportunities for care.
The timing of the reauthorization effort is especially significant. During ALS Awareness Month, ALS United member organizations from across the country will be in Washington, D.C. meeting with members of Congress and their staff to advocate for policies that strengthen ALS research funding, improve care access, and support families impacted by the disease. Reauthorizing the ACT for ALS Act will be one of the key priorities raised during these meetings.
ALS United Mid-Atlantic is grateful to Senators Murkowski and Coons for their bipartisan leadership and commitment to the ALS community. Their support reflects a shared understanding that continued progress is needed to build on the momentum of the original legislation and ensure that research efforts are not interrupted.
As this legislation moves forward, community voices remain essential. Advocates can help build momentum by contacting their members of Congress and asking them to cosponsor the ACT for ALS Reauthorization Act. Public support plays a vital role in ensuring lawmakers understand the importance of sustained ALS research funding and expanded access opportunities.
Together, we can continue advancing research, improving access to care, and supporting every person and family affected by ALS.
Together, We End ALS.